NIGMS Continues Its MIRA Program
We’ve issued a funding opportunity announcement (FOA) PAR-19-367
to maintain continued support of our Maximizing
Investigators’ Research Award (MIRA) program. Under this new FOA,
investigators with an active NIGMS R35 grant (both early-stage and established
investigator MIRA) can submit renewal MIRA applications, and investigators with
a single-PI R01-equivalent NIGMS award (DP1, DP2, R01, R37, SC1) can submit new
MIRA applications.
Some changes to this FOA include:
1. Eligibility: New MIRA applications should be submitted within the fiscal year that follows the fiscal year of the original project period expiration date of the qualifying award. Renewal MIRA applications should be submitted within the two fiscal years that follow the fiscal year of the original project period expiration date of the current R35 MIRA. Please note that the original project expiration date is the sole determinant of eligibility; a no-cost extension to a qualifying award will not increase the eligibility time window.
2. Budget: An
itemized or detailed budget request is no longer required and will not be
accepted. Applicants are instructed to request a total direct cost amount for
each budget year. Additional funds for well-justified equipment purchases can
be requested. Inflationary increases in future years will not be allowed.
3. Other
changes:
The FOA is now clinical trial optional. Early applications will be accepted, but
because an ongoing award will be replaced, a MI...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Chrissa Chverchko Tags: Funding Opportunities Research Administration Early Stage Investigator Established Investigator Funding Policies MIRA Source Type: blogs